Advanced search
Publication Cover
OncoImmunology Volume 13, 2024 - Issue 1
Submit an article Journal homepage
333
Views
0
CrossRef citations to date
0
Altmetric
Original research

Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment

Camille Chatelaina Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Laurine Berlanda Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Marion Grarda Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Nicolas Jouandb LabEx IGO, Nantes Université, Nantes, France;c Nantes Université, CHU Nantes, CNRS, Inserm, BioCore, US16, SFR Bonamy, Nantes, FranceView further author information
,
Judith Fresqueta Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Joëlle Nadera Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Ugo Hirigoyena Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Tacien Petithommea Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Chantal Combredetd Vaccines Innovation Laboratory, Institut Pasteur, Université de Paris Cité, Paris, FranceView further author information
,
Elvire Pons-Tostivinta Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, France;e Centre Hospitalier Universitaire Nantes, Medical Oncology, Nantes University, Nantes, FranceView further author information
,
Delphine Fradina Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Lucas Trepsa Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Christophe Blanquarta Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Nicolas Boisgeraulta Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceView further author information
,
Frédéric Tangyd Vaccines Innovation Laboratory, Institut Pasteur, Université de Paris Cité, Paris, France;f Oncovita, Paris, FranceView further author information
&
Jean-François Fonteneaua Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, Nantes, France;b LabEx IGO, Nantes Université, Nantes, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3284-8319View further author information
ORCID Icon show all
Article: 2377830 | Received 24 Jan 2024, Accepted 04 Jul 2024, Published online: 10 Jul 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.